These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7906190)

  • 21. The assessment of lamotrigine, an antiepileptic drug, in the treatment of tinnitus.
    Simpson JJ; Gilbert AM; Weiner GM; Davies WE
    Am J Otol; 1999 Sep; 20(5):627-31. PubMed ID: 10503585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study.
    Biton V; Di Memmo J; Shukla R; Lee YY; Poverennova I; Demchenko V; Saiers J; Adams B; Hammer A; Vuong A; Messenheimer J
    Epilepsy Behav; 2010 Nov; 19(3):352-8. PubMed ID: 20937567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression.
    Schaffer A; Zuker P; Levitt A
    J Affect Disord; 2006 Nov; 96(1-2):95-9. PubMed ID: 16820213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials.
    Meininger V; Bensimon G; Bradley WR; Brooks B; Douillet P; Eisen AA; Lacomblez L; Leigh PN; Robberecht W
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):107-17. PubMed ID: 15204012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of lamotrigine on depressive symptoms in adult patients with epilepsy.
    Ettinger AB; Kustra RP; Hammer AE
    Epilepsy Behav; 2007 Feb; 10(1):148-54. PubMed ID: 17071141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Possible detrimental effects of lamotrigin in amyotrophic lateral sclerosis].
    Zarranz JJ; Ciordia R
    Neurologia; 1995 Feb; 10(2):116. PubMed ID: 7695942
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis.
    Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Petropoulou O; Zis V; Sfagos C; Vassilopoulos D
    In Vivo; 2008; 22(1):137-41. PubMed ID: 18396796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lamotrigine--antiparkinsonian activity by blockade of glutamate release?
    Zipp F; Baas H; Fischer PA
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):67-75. PubMed ID: 8094961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients?
    Pinto S; Pinto A; De Carvalho M
    Eura Medicophys; 2007 Dec; 43(4):505-9. PubMed ID: 18084174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized sequential trial of creatine in amyotrophic lateral sclerosis.
    Groeneveld GJ; Veldink JH; van der Tweel I; Kalmijn S; Beijer C; de Visser M; Wokke JH; Franssen H; van den Berg LH
    Ann Neurol; 2003 Apr; 53(4):437-45. PubMed ID: 12666111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder.
    Hertzberg MA; Butterfield MI; Feldman ME; Beckham JC; Sutherland SM; Connor KM; Davidson JR
    Biol Psychiatry; 1999 May; 45(9):1226-9. PubMed ID: 10331117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical trial of dextromethorphan in amyotrophic lateral sclerosis.
    Gredal O; Werdelin L; Bak S; Christensen PB; Boysen G; Kristensen MO; Jespersen JH; Regeur L; Hinge HH; Jensen TS
    Acta Neurol Scand; 1997 Jul; 96(1):8-13. PubMed ID: 9262126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis.
    Louwerse ES; Weverling GJ; Bossuyt PM; Meyjes FE; de Jong JM
    Arch Neurol; 1995 Jun; 52(6):559-64. PubMed ID: 7763202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of lamotrigine on hippocampal activation in corticosteroid-treated patients.
    Brown ES; Zaidel L; Allen G; McColl R; Vazquez M; Ringe WK
    J Affect Disord; 2010 Nov; 126(3):415-9. PubMed ID: 20580827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial.
    Kremer B; Clark CM; Almqvist EW; Raymond LA; Graf P; Jacova C; Mezei M; Hardy MA; Snow B; Martin W; Hayden MR
    Neurology; 1999 Sep; 53(5):1000-11. PubMed ID: 10496259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled trial of nimodipine in amyotrophic lateral sclerosis.
    Miller RG; Shepherd R; Dao H; Khramstov A; Mendoza M; Graves J; Smith S
    Neuromuscul Disord; 1996 Mar; 6(2):101-4. PubMed ID: 8664560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind placebo-controlled trial of L-threonine in amyotrophic lateral sclerosis.
    Blin O; Pouget J; Aubrespy G; Guelton C; Crevat A; Serratrice G
    J Neurol; 1992 Feb; 239(2):79-81. PubMed ID: 1313078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind, placebo-controlled trial of high doses of gangliosides in amyotrophic lateral sclerosis.
    Lacomblez L; Bouche P; Bensimon G; Meininger V
    Neurology; 1989 Dec; 39(12):1635-7. PubMed ID: 2685660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic trial of tilorone in ALS: lack of benefit in a double-blind, placebo-controlled study.
    Olson WH; Simons JA; Halaas GW
    Neurology; 1978 Dec; 28(12):1293-5. PubMed ID: 366454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ganglioside therapy for amyotrophic lateral sclerosis: a double-blind controlled trial.
    Harrington H; Hallett M; Tyler HR
    Neurology; 1984 Aug; 34(8):1083-5. PubMed ID: 6379507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.